Risk of secondary cancer from receiving CAR-T therapies is low, large study finds
The United States Food and Drug Administration (FDA) issued a warning in 2023 about a…
0 Comments
A new study finds that triple-negative breast cancer tumors with increased immune cells have a lower risk of recurrence after surgery, even when not treated with chemotherapy
ROCHESTER, Minn. — A new multicenter, international study indicates that people who have early-stage triple-negative…
0 Comments